Abdi İbrahim was founded in 1912 and has been the leader of Turkey’s Pharmaceutical Industry for 17 years, and boasts the largest product portfolio in the sector, with more than 200 brands and over 450 products.
MANAGING DIRECTOR, GENERAL MANAGER & BUSINESS STRATEGY CONSULTANT, HASBIOTECH
Founded in 2009, Hasbiotech is driven to create and manufacture an original Turkish medicine starting from scratch and is establishing a manufacturing site for local production of biotechnological products.
Tüm Ekip Pharmaceuticals was established in 2000 and is a specialized injectable pharmaceutical producer, with capability to produce seven different sterile forms.
Established in the year 2002, Surya Life Sciences is a manufacturer, exporter, and supplier of a wide assortment of bulk drug intermediates and fine API chemicals.
Centurion Pharma was founded in 1979, and today imports products for the treatment of rare diseases as well as biological, biotechnological and hospital products. Centurion has also taken steps to develop and manufacture products locally by establishing an R&D Department in 2011.
Sanofi has a diversified portfolio, ranging from innovative medicines including rare diseases, immunology, diabetes and cardiovascular to consumer healthcare products and vaccines.
CHIEF SENIOR RESEARCHER, TUBITAK MAM, GENETIC ENGINEERING AND BIOTECHNOLOGY INSTITUTE (GEBI)
The Genetic Engineering and Biotechnology Institute (GEBI) conducts researches and develops technologies in the field of genetic engineering and biotechnology with high added value by taking into consideration the developments in the world and the needs of the public and industrial sectors in Turkey.
The pre-release edition of Africa Energy 2024 comprises analysis based on over 80 interviews with ministers and leading executives from IOCs, NOCs, independents, associations, investors and service providers, to provide an in-depth and holistic view of sub-Saharan Africa’s ever-evolving energy sector.